Atara Biotherapeutics, Inc. - Common Stock (ATRA)
CUSIP: 046513107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,165,808
- Total 13F shares
- 87,844,034
- Share change
- +3,796,908
- Total reported value
- $1,572,372,278
- Put/Call ratio
- 62%
- Price per share
- $17.90
- Number of holders
- 138
- Value change
- +$69,603,688
- Number of buys
- 66
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 046513107:
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2021
As of 30 Sep 2021,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
87,844,034 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, JPMORGAN CHASE & CO, MAVERICK CAPITAL LTD, BlackRock Inc., VANGUARD GROUP INC, Redmile Group, LLC, FMR LLC, STATE STREET CORP, WASATCH ADVISORS INC, and GOLDMAN SACHS GROUP INC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
144
Q3 2021 holders
138
Holder diff
-6
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.